Revised forecast
Fiscal year ending March 2027 · Full yearThe bar length represents the relative magnitude of change, based on the item that changed the most in this document.
For the fiscal year ended March 2026, higher revenue and profit in the Seasonings and Foods, Healthcare and other segments, strong sales of electronic materials, and a gain on the sale of fixed assets arising from the transfer of the land and building for the head office affected results. For the fiscal year ending March 2027, the main assumptions are an exchange rate of ¥150 to the US dollar, moderate global economic growth and generally stable raw material and fuel prices. The company will pursue price adjustments and cost reductions in response to higher raw material, fuel and logistics costs. The impact of escalating tensions in the Middle East is not included in the earnings forecasts.
Impairment losses and reversal of impairment losses: ¥8,450 million (as stated in the consolidated statement of cash flows)
| Item | Details |
|---|---|
| Net Sales | Not disclosed → ¥1,723,000 million |
| Profit attributable to owners of the parent | Not disclosed → ¥120,000 million |
| Net income per share | Not disclosed → 126.16 yen and sen |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Full year |
| Previous-period results | Revenue: ¥1,583,719 million; business profit: ¥181,163 million; profit for the year attributable to owners of the parent: ¥134,675 million; basic earnings per share: ¥138.36 |
| Reason for the revision | For the fiscal year ended March 2026, higher revenue and profit in the Seasonings and Foods, Healthcare and other segments, strong sales of electronic materials, and a gain on the sale of fixed assets arising from the transfer of the land and building for the head office affected results. For the fiscal year ending March 2027, the main assumptions are an exchange rate of ¥150 to the US dollar, moderate global economic growth and generally stable raw material and fuel prices. The company will pursue price adjustments and cost reductions in response to higher raw material, fuel and logistics costs. The impact of escalating tensions in the Middle East is not included in the earnings forecasts. |
| Details and amount of extraordinary loss | Impairment losses and reversal of impairment losses: ¥8,450 million (as stated in the consolidated statement of cash flows) |
| Dividend forecast revision | The annual dividend for the fiscal year ending March 2027 is expected to be ¥50, comprising an interim dividend of ¥25 and a year-end dividend of ¥25, an increase of ¥2 from the ¥48 annual dividend for the fiscal year ended March 2026. |
| Consolidated / non-consolidated | Consolidated / non-consolidated (standalone) |
Items this document does not state (3)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.For the fiscal year ended March 2026, business profit increased due to higher revenue and profit in the Seasonings and Foods, Healthcare and other segments, as well as strong sales of electronic materials. In addition, a gain on the sale of fixed assets arising from the transfer of the land and building for the head office pushed up operating profit. For the fiscal year ending March 2027, the company assumes moderate global economic growth, price adjustments and cost reductions, while stating that the impact of higher raw material, fuel and logistics costs and the situation in the Middle East remains highly uncertain.